2047 completed, 677 unknown, 318 terminated, 233 recruiting. 3627 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3627 | Completed 2047, Unknown 677, Terminated 318, Recruiting 233, Withdrawn 141, Not yet recruiting 115, Active not recruiting 69, Enrolling by invitation 15, Suspended 12 |
Follow Urogenital Diseases: new trials by email Literature Review of Urogenital Diseases trials Research Report on Urogenital Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antibiotics for Kidney Transplant Recipients Trimethoprim-Sulfamethoxazole (TMP-SMX), Usual Care - Kidney Transplant, Urinary Tract Infection(UTI) | Phase 4 | Not yet recruiting | University of California, San Francisco | 50 | 2028-10-01 | 2026-09-11 |
| Perioperative Esketamine Safety and Efficacy in Reducing Postoperative ENDometriosis PAIN (the ENDPAIN Trial): a Randomized Controlled Trial. Esketamine, Placebo - Endometriosis | Phase 4 | Not yet recruiting | Region Skane | 1000 | 2028-01-01 | 2026-10-19 |
| Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children Urgent PC - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Not yet recruiting | Chi Dang Hornik | 50 | 2027-04-01 | 2026-06-17 |
| Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD Naoxintong Capsule, Placebo - Diabetic Nephropathy | Phase 4 | Not yet recruiting | Chen Xiangmei | 410 | 2027-03-01 | 2026-07-13 |
| Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain Biospecimen Collection, Low-Dose Aspirin, Patient Observation - Endometrial Carcinoma | Phase 4 | Not yet recruiting | Mayo Clinic | 20 | 2027-02-12 | 2026-08-05 |
| Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus | Phase 4 | Not yet recruiting | Eunice Dube | 2140 | 2027-01-30 | 2026-07-30 |
| Combating Related Epidemics in HCV Cepheid GeneXpert HCV Test, Abbott Determine HIV - 1/2 Ag/Ab, Abbott Determine HbsAg 2 - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV) | Phase 4 | Not yet recruiting | Duke University | 1280 | 2027-01-20 | 2026-10-15 |
| Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access Semaglutide, Virtual Weight Management Coaching - Obesity, Chronic Kidney Disease | Phase 4 | Not yet recruiting | Kristin Clemens | 880 | 2027-01-01 | 2026-10-05 |
| SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer GLP-1 Receptor Agonist, Levonorgestrel IUD (Lng-IUD), Oral Progestins - Endometrial Cancer, Endometrial Cancer Stage I | Phase 4 | Not yet recruiting | Hospital Universitari de Bellvitge | 80 | 2027-01-01 | 2026-06-10 |
| Reaching Persons With HIV Who Are Out of Care Through Expedited Access to Long-Acting Injectable Antiretroviral Therapy - The RELAI Study Field-based LA-CAB/RPV - HIV Infection | Phase 4 | Not yet recruiting | University of North Carolina, Chapel Hill | 40 | 2027-01-01 | 2026-10-26 |
| Efficacy and Safety of Obinutuzumab Beta in Primary IgA Nephropathy With Active Pathological Lesions Obinutuzumab Beta - Primary IgA Nephropathy | Phase 4 | Not yet recruiting | Ruijin Hospital | 20 | 2026-12-10 | 2026-10-22 |
| Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial) Tamsulosin hydrochloride 0.2 mg, Placebo - Benign Prostatic Hyperplasia | Phase 4 | Not yet recruiting | Shanghai East Hospital | 400 | 2026-12-01 | 2026-09-29 |
| Heart-Kidney-Diabetes Multidisciplinary Care MOdels for CardiovascuLar Health In Patients With Chronic Kidney DiSease and Diabetes: A PragmaTIC Cluster Randomized Controlled Trial (HOLISTIC) The intervention with the MCM is Kidney-Heart GDMT initiation and titration for dose optimization (as clinically tolerated), within 4 months of enrollment in the study. - Chronic Kidney Disease, Type II Diabetes | Phase 4 | Not yet recruiting | Baim Institute for Clinical Research | 570 | 2026-12-01 | 2026-09-10 |
| Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease mirabegron, Exercise-based behavioral therapy - Overactive Bladder, Parkinson Disease | Phase 4 | Not yet recruiting | VA Office of Research and Development | 146 | 2026-11-09 | 2026-10-27 |
| Tucatinib Continuation Study tucatinib - HER2-positive Breast Cancer, Cervical Cancer | Phase 4 | Not yet recruiting | Pfizer | 175 | 2026-11-06 | 2026-08-28 |
| A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44) Pembrolizumab, Cisplatin, 5-Fluorouracil - Neoplasm Malignant, Gastric Neoplasms | Phase 4 | Not yet recruiting | Merck Sharp & Dohme LLC | 150 | 2026-11-06 | 2026-09-03 |
| Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery Suzetrigine, Opioid Analgesics (Tramadol or Oxycodone), Scheduled Acetaminophen and Ibuprofen - Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI) | Phase 4 | Not yet recruiting | University of California, Los Angeles | 120 | 2026-11-01 | 2026-09-15 |
| IPP Placement & Intracavernosal Block Exparel/bupivacaine mixture - Erectile Dysfunction (ED) | Phase 4 | Not yet recruiting | Wake Forest University Health Sciences | 100 | 2026-11-01 | 2026-09-24 |
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer. Darolutamide, Physician choice Androgen Deprivation (Hormone) Therapy - Prostate Cancer | Phase 4 | Not yet recruiting | University of Chicago | 80 | 2026-11-01 | 2026-01-08 |
Showing 20 of 3627. Sign in to see all of them.
HIV Infections (413) · Renal Insufficiency, Chronic (312) · Infertility (254) · Kidney Failure, Chronic (236) · Acquired Immunodeficiency Syndrome (211) · Urinary Bladder, Overactive (134) · Renal Insufficiency (132) · Prostatic Neoplasms (122) · Polycystic Ovary Syndrome (120) · Premature Birth (118) · Acute Kidney Injury (107) · Erectile Dysfunction (103) · Urinary Tract Infections (102) · Prostatic Hyperplasia (94) · Kidney Diseases (93)
Female Urogenital Diseases and Pregnancy Complications (2462) · Female Urogenital Diseases (2031) · Male Urogenital Diseases (1915) · Genital Diseases (1712) · Urologic Diseases (1509) · Pathological Conditions, Signs and Symptoms (1357) · Kidney Diseases (990) · Pathologic Processes (913) · Infections (869) · Immune System Diseases (678) · Communicable Diseases (675) · Virus Diseases (652) · Disease Attributes (636) · Sexually Transmitted Diseases (635)
Metformin (77) · Ritonavir (61) · Lamivudine (58) · Saline Solution (58) · Tenofovir (57) · Sildenafil Citrate (49) · efavirenz (48) · Emtricitabine (47) · Progesterone (46) · Tamsulosin (46) · Estradiol (45) · Sodium Chloride (45) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (43) · Solifenacin Succinate (42) · Tacrolimus (42)
Mansoura University (36) · University of California, San Francisco (34) · Cairo University (30) · GlaxoSmithKline (30) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (30) · University of Washington (29) · Bayer (28) · University Magna Graecia (25) · Assiut University (24) · Novartis (21) · Germans Trias i Pujol Hospital (20) · Astellas Pharma Inc (19) · Brigham and Women's Hospital (18) · Novartis Pharmaceuticals (18) · Seoul National University Hospital (18)
United States (1037) · China (252) · Spain (209) · Egypt (190) · Italy (182) · Canada (166) · France (151) · South Korea (124) · Brazil (111) · Denmark (108) · United Kingdom (105) · Netherlands (96) · Germany (92) · Belgium (68) · Thailand (67)
Stefano Palomba, MD (22) · Mohamed S Abdelhafez, Dr (12) · Kyu-Sung Lee, Ph.D (10) · Fulvio Zullo, MD (9) · Francesco Orio, MD (8)
PMID 37160401, PMID 35224730, PMID 33314078, PMID 41276263, PMID 38018702, PMID 36416787, PMID 36791280, PMID 37815037, PMID 38299639, PMID 33586138, PMID 38682786, PMID 38770818, PMID 39356039, PMID 40576086, PMID 28892218, PMID 34519356, PMID 34778952, PMID 35230699, PMID 35947046, PMID 37916745, PMID 18328118, PMID 22225814, PMID 32588430, PMID 37888839, PMID 39963952, PMID 41701614, PMID 10411041, PMID 18305265, PMID 19524353, PMID 19617207, PMID 19684043, PMID 20554319, PMID 23334883, PMID 23857221, PMID 23985562, PMID 24009220, PMID 25297720, PMID 25443519, PMID 26032537, PMID 26630142, PMID 27483065, PMID 27529295, PMID 27640943, PMID 28143456, PMID 28657417, PMID 28763548, PMID 29450636, PMID 29588190, PMID 29600824, PMID 29939940
2008 (13), 2018 (12), 2023 (12), 2009 (11), 2025 (11), 2015 (10), 2014 (9), 2016 (9), 2019 (8), 2004 (7), 2005 (6), 2017 (5), U01AI068632 (4), U01AI068636 (4), R01AI145971 (2)